Cargando…
Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
AIM: To assess attitudes and beliefs towards benign prostatic hyperplasia (BPH)/ lower urinary tract symptoms (LUTS) and its treatment among patients and physicians in Latin America, Asia Pacific and the Commonwealth of Independent States (CIS). METHODS: Cross‐sectional, quantitative study conducted...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129547/ https://www.ncbi.nlm.nih.gov/pubmed/27774780 http://dx.doi.org/10.1111/ijcp.12879 |
_version_ | 1782470607800107008 |
---|---|
author | Ertel, Phillip Adalig, Burkay Demircan, Ipek Lartey, Belinda Manyak, Michael J |
author_facet | Ertel, Phillip Adalig, Burkay Demircan, Ipek Lartey, Belinda Manyak, Michael J |
author_sort | Ertel, Phillip |
collection | PubMed |
description | AIM: To assess attitudes and beliefs towards benign prostatic hyperplasia (BPH)/ lower urinary tract symptoms (LUTS) and its treatment among patients and physicians in Latin America, Asia Pacific and the Commonwealth of Independent States (CIS). METHODS: Cross‐sectional, quantitative study conducted between December 2014 and September 2015. Separate questionnaires were administered to BPH/LUTS patients receiving drug treatment for their condition and to practising physicians who treat patients with BPH/LUTS. RESULTS: In total, 1094 patients and 202 physicians completed a questionnaire. Most patients (61%) felt very/fairly well informed about BPH/LUTS, and 60% of physicians perceived patients to be very/somewhat informed. Overall, 70% of physicians felt that it would be valuable to raise awareness of BPH/LUTS and encourage men to consult a physician. The first symptoms most commonly noticed by patients were need to urinate more frequently, slower/weaker stream and nocturia. At first consultation, 71% of patients recalled providing a urine sample, 57% having a blood test for prostate‐specific antigen and 56% a digital rectal examination being performed. Over two thirds of patients (69%) were satisfied with their current medication; highest satisfaction rates (among both patients and physicians) were reported for alpha blockers and 5ARIs, either as monotherapies or used in combination. Patients were prepared to wait longer for symptom relief in order to have a reduced risk of surgery. Most physicians (90%) thought that at least some patients believe BPH/LUTS to be a progressive condition. Most physicians thought that patients were very/fairly concerned about BPH surgery (92%) and acute urinary retention (72%); 52% of physicians thought treatment adherence was “extremely” important. CONCLUSIONS: This study provides valuable insights into the attitudes and beliefs of patients and physicians in Asia Pacific, Latin America and CIS about BPH/LUTS and its management. It also highlights areas of discordance between patient/physician perceptions and beliefs about BPH/LUTS, and potential areas of focus to improve the experience of affected patients. |
format | Online Article Text |
id | pubmed-5129547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51295472016-11-30 Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey Ertel, Phillip Adalig, Burkay Demircan, Ipek Lartey, Belinda Manyak, Michael J Int J Clin Pract Urology AIM: To assess attitudes and beliefs towards benign prostatic hyperplasia (BPH)/ lower urinary tract symptoms (LUTS) and its treatment among patients and physicians in Latin America, Asia Pacific and the Commonwealth of Independent States (CIS). METHODS: Cross‐sectional, quantitative study conducted between December 2014 and September 2015. Separate questionnaires were administered to BPH/LUTS patients receiving drug treatment for their condition and to practising physicians who treat patients with BPH/LUTS. RESULTS: In total, 1094 patients and 202 physicians completed a questionnaire. Most patients (61%) felt very/fairly well informed about BPH/LUTS, and 60% of physicians perceived patients to be very/somewhat informed. Overall, 70% of physicians felt that it would be valuable to raise awareness of BPH/LUTS and encourage men to consult a physician. The first symptoms most commonly noticed by patients were need to urinate more frequently, slower/weaker stream and nocturia. At first consultation, 71% of patients recalled providing a urine sample, 57% having a blood test for prostate‐specific antigen and 56% a digital rectal examination being performed. Over two thirds of patients (69%) were satisfied with their current medication; highest satisfaction rates (among both patients and physicians) were reported for alpha blockers and 5ARIs, either as monotherapies or used in combination. Patients were prepared to wait longer for symptom relief in order to have a reduced risk of surgery. Most physicians (90%) thought that at least some patients believe BPH/LUTS to be a progressive condition. Most physicians thought that patients were very/fairly concerned about BPH surgery (92%) and acute urinary retention (72%); 52% of physicians thought treatment adherence was “extremely” important. CONCLUSIONS: This study provides valuable insights into the attitudes and beliefs of patients and physicians in Asia Pacific, Latin America and CIS about BPH/LUTS and its management. It also highlights areas of discordance between patient/physician perceptions and beliefs about BPH/LUTS, and potential areas of focus to improve the experience of affected patients. John Wiley and Sons Inc. 2016-10-23 2016-10 /pmc/articles/PMC5129547/ /pubmed/27774780 http://dx.doi.org/10.1111/ijcp.12879 Text en © 2016 GlaxoSmithKline. International Journal of Clinical Practice Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Urology Ertel, Phillip Adalig, Burkay Demircan, Ipek Lartey, Belinda Manyak, Michael J Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey |
title | Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey |
title_full | Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey |
title_fullStr | Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey |
title_full_unstemmed | Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey |
title_short | Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey |
title_sort | understanding patient and physician perceptions of benign prostatic hyperplasia in asia pacific, latin america and the commonwealth of independent states: the prostate research on behaviour and education (probe) ii survey |
topic | Urology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129547/ https://www.ncbi.nlm.nih.gov/pubmed/27774780 http://dx.doi.org/10.1111/ijcp.12879 |
work_keys_str_mv | AT ertelphillip understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey AT adaligburkay understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey AT demircanipek understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey AT larteybelinda understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey AT manyakmichaelj understandingpatientandphysicianperceptionsofbenignprostatichyperplasiainasiapacificlatinamericaandthecommonwealthofindependentstatestheprostateresearchonbehaviourandeducationprobeiisurvey |